27 results on '"Polydefkis, Michael J."'
Search Results
2. PAIN HYPERSENSITIVITY IN SLURP1 AND SLURP2 KNOCKOUT MOUSE MODELS OF HEREDITARY PALMOPLANTAR KERATODERMA
3. Pain Hypersensitivity in SLURP1 and SLURP2 Knock-out Mouse Models of Hereditary Palmoplantar Keratoderma.
4. An oral form of methylglyoxal-bis-guanylhydrazone reduces monocyte activation and traffic to the dorsal root ganglia in a primate model of HIV-peripheral neuropathy
5. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations
6. Monocyte Traffic, Dorsal Root Ganglion Histopathology, and Loss of Intraepidermal Nerve Fiber Density in SIV Peripheral Neuropathy
7. The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types
8. Reducing monocarboxylate transporter MCT1 worsens experimental diabetic peripheral neuropathy
9. Peripheral Nerve Toxic Effects of Nitrofurantoin
10. Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis
11. Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during aging
12. Monocarboxylate transporter 1 in Schwann cells is critical for maintenance of sensory nerve myelination during aging
13. Long-Term Efficacy and Safety of Inotersen for Hereditary Transthyretin Amyloidosis: NEURO-TTR Open-Label Extension 2-Year Update (S27.008)
14. Responsiveness of Neuropathy Symptom and Change (NSC) Score Components in Inotersen Treatment of Hereditary Transthyretin Amyloidosis Polyneuropathy (P3.9-060)
15. Long-Term Update from the Open-Label Extension of the NEURO-TTR Study in Patients with Hereditary Transthyretin Amyloidosis
16. Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during aging.
17. Open Label Extension of the Phase 3 Study NEURO-TTR to Assess the Long-term Efficacy and Safety of Inotersen in Patients With Hereditary Transthyretin Amyloidosis (P1.324)
18. Safety and Efficacy of Inotersen in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (NEURO-TTR) (N2.001)
19. Burden of Hereditary Transthyretin Amyloidosis With Polyneuropathy in Patients Enrolled in the Phase 3 Study NEURO-TTR (P1.331)
20. Inotersen Improves Norfolk Quality of Life-Diabetic Neuropathy Measures in Patients With Hereditary Transthyretin Amyloidosis with Polyneuropathy in the Phase 3 Study NEURO-TTR (S5.006)
21. Loss of intraepidermal nerve fiber density during SIV peripheral neuropathy is mediated by monocyte activation and elevated monocyte chemotactic proteins
22. Research design considerations for chronic pain prevention clinical trials
23. Herpes Zoster Among Persons Living With HIV in the Current Antiretroviral Therapy Era
24. The Incidence of, Risk Factors for, and Sequelae of Herpes Zoster Among HIV Patients in the Highly Active Antiretroviral Therapy Era
25. Herpes zoster among persons living with HIV in the current antiretroviral therapy era.
26. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.
27. Peripheral neuropathy and HIV.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.